Skip to main content
. Author manuscript; available in PMC: 2017 Aug 15.
Published in final edited form as: JAMA. 2011 Jan 12;305(2):151–159. doi: 10.1001/jama.2010.1972

Table 3.

Outcomes and Adherence at Six and Twelve Months

Behavior Behavior Plus P value

Percent Improvement in Incontinence Episodes on 7-Day Bladder Diary, mean (95% CI*)
  6 Months Post-Treatment, n = 91 55.9% (46.1–65.7%) 52.8% (36.4–69.1%) .74
Mean episodes per week (95% CI) 12.6 (8.7–16.6) 14.6 (7.0–22.1)
  12 Months Post-Treatment, n = 81 50.4% (39.8–61.1%) 59.0% (45.0–73.1%) .32
Mean episodes per week (95% CI) 13.5 (9.5–17.5) 9.1 (4.6–13.6)

Change in EPIC, mean (95% CI)
Urinary Domain
  6 Months Post-Treatment, n = 98 12.2 (9.5–14.9) 7.2 (4.0–10.4) .10
  12 Months Post-Treatment, n = 82 12.0 (8.2–15.7) 9.9 (6.2–13.7) .49
Incontinence Subscale
  6 Months Post-Treatment, n = 98 14.7 (9.7–19.6) 10.1 (6.4–13.8) .19
  12 Months Post-Treatment, n = 82 14.4 (8.9–19.8) 13.3 (7.7–18.8) .97

Change in IIQ, ‡‡ median (range)
Physical Activity subscale
  6 Months Post-Treatment, n = 97 −.5.6 (−72.2–61.1) −5.6 (−83.3–61.1) .71
  12 Months Post-Treatment, n = 82 −5.6 (−77.8–50.0) −5.6 (−83.3–77.8) .06
Travel subscale
  6 Months Post-Treatment, n = 97 −5.6 (−80.0–22.2) −5.6 (−61.1–77.8) .99
  12 Months Post-Treatment, n = 82 −2.8 (−72.2–22.2) −7.8 (−72.2–22.2) .03
Social Relationships subscale
  6 Months Post-Treatment, n = 97 −3.3 (−63.3–26.7) −4.2 (−64.8–50.0) .87
  12 Months Post-Treatment, n = 81 −3.3 (−56.7–30.0) −3.3 (−68.1–22.6) .06
Emotional subscale
  6 Months Post-Treatment, n = 97 −6.7 (−66.7–25.0) −4.2 (−83.3–62.5) .93
  12 Months Post-Treatment, n = 81 0.0 (−66.7–33.3) −4.2 (−66.7–54.2) .10
Total Score
  6 Months Post-Treatment, n = 97 −16.9 (−242.2–95.6) −12.2 (−214.8–188.9) .92
  12 Months Post-Treatment, n = 81 −14.6 (−256.7–99.4) −19.2 (−238.9–176.8) .04

Change in SF-36, ‡‡‡ mean (95% CI)
Physical Component Summary
  6 Months Post-Treatment, n = 97 1.3 (−0.3–2.9) 1.8 (−0.0–3.7) .38
  12 Months Post-Treatment, n = 81 0.5 (−1.4–2.3) 1.1 (−0.7–3.0) .51
Mental Component Summary
  6 Months Post-Treatment, n = 97 −0.8 (−3.5–1.9) 0.5 (−1.4–2.4) .18
  12 Months Post-Treatment, n = 81 0.2 (−2.6–3.1) 0.2 (−1.7–2.2) .64

Change in AUA-SI§ scores, mean (95% CI)
Total Score
  6 Months Post-Treatment, n = 98 −3.9 (−5.3 – −2.6) −2.5 (−3.8 – −1.2) .53
  12 Months Post-Treatment, n = 84 −3.4 (−4.9 – −1.9) −2.1 (−3.2 – −1.1) .94
Voiding Subscale
  6 Months Post-Treatment, n = 98 −1.6 (−2.3 – −0.9) −0.6 (−1.2–0.1) .26
  12 Months Post-Treatment, n = 84 −1.3 (−2.1 – −0.5) −0.2 (−0.8–0.4) .42
Storage Subscale
  6 Months Post-Treatment, n = 98 −2.3 (−3.1 – −1.5) −1.9 (−2.8 – −1.0) .90
  12 Months Post-Treatment, n = 84 −2.1 (−3.0 – −1.2) −1.9 (−2.7 – −1.1) .50

IPSS QOL§§ “If you were to spend the rest of your life with your urinary problem the way it is now, how would you feel about that?” n (%) .95
  6 Months Post-Treatment, n = 98 2 (4.0%) 2 (4.2%)
    Delighted 9 (18.0%) 8 (16.7%)
    Pleased 12 (24.0%) 12 (25.0%)
    Mostly satisfied 15 (30.0%) 13 (27.1%)
    Mixed 7 (14.0%) 10 (20.8%)
    Mostly dissatisfied 3 (6.0%) 1 (2.1%)
    Unhappy 2 (4.0%) 2 (4.2%)
    Terrible .13
  12 Months Post-Treatment, n = 84 2 (4.4%) 3 (7.9%)
    Delighted 12 (26.1%) 8 (21.1%)
    Delighted 8 (17.4%) 17 (44.7%)
    Mostly satisfied 13 (28.3%) 5 (13.2%)
    Mixed 7 (15.2%) 4 (10.5%)
    Mostly dissatisfied 3 (6.5%) 1 (2.6%)
    Unhappy 1 (2.2%) 0 (0.0%)
    Terrible

Global Perception of Improvement: (GPI) n (%)
“Better” or “much better” vs. “same”, “worse” or “much worse”
  6 Months Post-Treatment, n = 94 39 (84.8%) 34 (70.8%) .11
  12 Months Post-Treatment, n = 82 42 (91.3%) 30 (83.3%) .27

Able to Wear Less Protection Now than Before Treatment
6 Months Post-Treatment, n = 95 .853
  Yes 26 (55.3%) 24 (50.0%)
  No 18 (38.3%) 20 (41.7%)
  Never used protection 3 (6.4%) 4 (8.3%)
12 Months Post-Treatment, n = 84 .913
  Yes 25 (54.4%) 19 (50.0%)
  No 17 (37.0%) 15 (39.5%)
  Never used protection 4 (8.7%) 4 (10.5%)

Activity Restriction due to Incontinence, n (%)
6 Months Post-Treatment, n = 95 .05
  Not at All 26 (55.3%) 36 (75.0%)
  Some of the time 20 (42.6%) 10 (20.8%)
  Most of the time 0 (0.0%) 2 (4.2%)
  All of the time 1 (2.1%) 0 (0.0%)
12 Months Post-Treatment, n = 84 .002
  Not at All 24 (52.2%) 32 (84.2%)
  Some of the time 22 (47.8%) 5 (13.2%)
  Most of the time 0 (0.0%) 1 (2.6%)
  All of the time 0 (0.0%) 0 (0.0%)

How Disturbing is the Leakage of Urine? n (%)
6 Months Post-Treatment, n = 95 .89
  Not at all (including not leaking now) 14 (29.8%) 13 (27.1%)
  Somewhat disturbing 31 (66.0%) 32 (66.7%)
  Extremely disturbing 2 (4.3%) 3 (6.3%)
12 Months Post-Treatment, n = 82 .15
  Not at all (including not leaking now) 13 (29.6%) 19 (50.0%)
  Somewhat disturbing 29 (65.9%) 17 (44.7%)
  Extremely disturbing 2 (4.6%) 2 (5.3%)
*

CI = Confidence Intervals

EPIC = Expanded Prostate Cancer Index Composite

‡‡

IIQ = Incontinence Impact Questionnaire

‡‡‡

SF-36 = Medical Outcomes Study 36-Item Short-Form Health Survey

§

AUA-7 = American Urological Association Symptom Index

§§

IPSS QOL = International Prostate Symptom Scale Quality of Life question

§§§

PSQ = Patient Satisfaction Question